Patent · US Active

Using adiponectin receptor agonists to treat inflammation and bone diseases in diabetes

US12098131B2 · kind B2 · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2023
Grant dateSep 24, 2024
Priority date—
Expiry dateApr 12, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are adiponectin receptor agonists and methods of using the same for the treatment of inflammation or bone loss in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.